Shankar Balasubramanian, Author at Cancer Research UK Cambridge Institute

Work address:: Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

: Chem-map profiles drug binding to chromatin in cells.

E-pub date: 1 Sep 2023

Journal name: Nat Biotechnol; Selective Functionalisation of 5‐Methylcytosine by Organic Photoredox Catalysis

E-pub date: 26 Jun 2023

Journal name: Angew Chem Int Ed Engl; Selective Functionalisation of 5‐Methylcytosine by Organic Photoredox Catalysis

E-pub date: 26 Jun 2023

Journal name: Angewandte Chemie

Company	Active	Research funding	Ownership	Royalty payments	Commitment to carry out work for a fee	Ad hoc reimbursed work	Travel	Gifts/ other
Biomodal (formerly known as Cambridge Epigenetix Limited)	Yes	No	Yes	No	Yes	No	No	No
Ahren Innovation Capital	Yes	No	Yes	No	Yes	No	No	No
BlueCat IP	Yes	No	Yes	Yes	No	No	No	No
Inflex Ltd	Yes	No	Yes	No	Yes	No	No	No
Elyx Limited	Yes	No	Yes	No	Yes	No	No	No
	No	No	No	No	No	No	No	No

Tweets